OakChart

Caredx Inc

CDNAHealthcare·Diagnostics & Research·USA·Mid·NASD·Nov 11 • 3:59 PM ET

81.17+0.40 (0.50%)
2026-11-11 23:24 CET
Market cap
4,243.88 USD m
Revenue, TTM
497.40 USD m
Net income, TTM
128.63 USD m
Free cash flow, TTM
59.76 USD m
EPS diluted, TTM
2.39
P/E
33.90
Compare

Price

CDNA against its 20, 50 and 200-day averages
2050200beat
20.0040.0060.0080.002.2M4.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CDNAclose 81.1720-day 75.4150-day 65.18200-day 36.1381.1752w high52w low

10.7% under the 52-week high of 90.87 on 30 Oct 2026. 52-week low 15.15 on 17 Nov 2025. Last 15 sessions, 36.0% high to low

Volume 0.58× normal · the line is the 50-bar volume average

Profile

CDNA
52-week range, 87% of the way up
15.1590.87

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

IndexRUT
Employees765
IPOJul 17, 2014
Beta2.50
ATR, 14d5.38
Rel volume0.58
Short float15.03%
Insider own8.98%
Inst own96.64%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.26B
Enterprise Value4.04B
Income128.63M
Sales497.40M
Book/sh8.91
Cash/sh4.77
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees765
IPOJul 17, 2014

Ratios

P/E33.90
Forward P/E51.89
PEG0.94
P/S8.57
P/B9.11
P/C17.03
P/FCF71.37
EV/EBITDA144.56
EV/Sales8.13
Quick Ratio2.25
Current Ratio2.31
Debt/Eq0.06
LT Debt/Eq0.04
Option/ShortYes / Yes

Earnings

EPS (ttm)2.39
EPS next Y1.56
EPS next Q0.36
EPS this Y206.65%
EPS next Y-12.05%
EPS next 5Y55.36%
EPS past 3/5Y34.67% 0.09%
Sales past 3/5Y5.68% 14.59%
EPS Y/Y TTM91.53%
Sales Y/Y TTM38.94%
EPS Q/Q1024.68%
Sales Q/Q39.29%
EarningsOct 29 AMC
EPS/Sales Surpr.174.73% 14.27%

Ownership

Insider Own8.98%
Insider Trans-7.80%
Inst Own96.64%
Inst Trans0.03%
ROA23.96%
ROE33.04%
ROIC26.37%
Gross Margin70.51%
Oper. Margin0.86%
Profit Margin25.86%
SMA207.64%
SMA5024.54%
SMA200124.68%
Trades-

Technical

Shs Outstand52.46M
Shs Float47.83M
Short Float15.03%
Short Ratio5.45
Short Interest7.19M
52W High90.87 -10.67%
52W Low15.15 435.78%
Volatility7.66% 7.02%
ATR (14)5.38
RSI (14)59.65
Beta2.50
Rel Volume0.58
Avg Volume1.32M
Volume770,604

Performance

Perf Week-5.46%
Perf Month24.06%
Perf Quarter71.32%
Perf Half Y293.84%
Perf YTD330.84%
Perf Year383.73%
Perf 3Y995.41%
Perf 5Y72.12%
Perf 10Y1929.25%
Recom1.50
Target Price94.43
Prev Close80.77
Price81.17
Change %0.50%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
TodayInitiatedPPiper SandlerOverweight$100+23.2%
Sep 02, 2026InitiatedCCanaccord GenuityBuy$65-19.9%
Aug 03, 2026UpgradeCCraig HallumHold → Buy$64-21.2%
Jan 06, 2026DowngradeCCraig HallumBuy → Hold$26-68.0%
Aug 26, 2025InitiatedWWilliam BlairMkt Perform
Jan 15, 2025UpgradeWWells FargoUnderweight → Equal Weight$28 → $24-70.4%
Aug 28, 2024InitiatedWWells FargoUnderweight$28-65.5%
Aug 19, 2024UpgradeBBTIG ResearchNeutral → Buy$40-50.7%
May 13, 2024DowngradeRRaymond JamesOutperform → Mkt Perform
May 01, 2024UpgradeCCraig HallumHold → Buy$15-81.5%

Peers

Mkt cap
TickerCompanyMkt cap
NTRANatera Inc46.38B
IMDXInsight Molecular Diagnostics Inc78.21M
TMOThermo Fisher Scientific Inc265.92B
VCYTVeracyte Inc2.03B
BLLNBilliontoone Inc5.27B
GHGuardant Health Inc20.94B
CSTLCastle Biosciences Inc1.05B
WGSGeneDx Holdings Corp1.65B
NEONeogenomics Inc2.18B
MYGNMyriad Genetics Inc548.68M

Insider trading

latest 14 of 61
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JEFFREY NOVACKOfficerNov 10 '26Proposed Sale84.424,096345,784Nov 10 04:25 PM
Kennedy KeithCFO & COONov 05 '26Option Exercise29.4352,4221,542,779261,108Nov 09 06:26 PM
Kennedy KeithCFO & COONov 05 '26Sale77.8261,9614,821,711199,147Nov 09 06:26 PM
KEITH S KENNEDYOfficerNov 05 '26Proposed Sale85.8679,2436,803,804Nov 05 04:27 PM
PETER MAAGDirectorAug 17 '26Proposed Sale46.389,122423,091Aug 17 04:06 PM
PETER MAAGDirectorAug 14 '26Proposed Sale45.307,000317,113Aug 14 06:09 PM
PETER MAAGDirectorAug 13 '26Proposed Sale47.077,000329,505Aug 13 04:19 PM
PETER MAAGDirectorAug 12 '26Proposed Sale46.897,000328,238Aug 12 04:08 PM
PETER MAAGDirectorAug 11 '26Proposed Sale47.697,000333,851Aug 11 06:12 PM
PETER MAAGDirectorAug 10 '26Proposed Sale47.666,902328,949Aug 10 06:23 PM
ARTHUR TORRESDirectorAug 10 '26Proposed Sale47.734,200200,475Aug 10 04:17 PM
PETER MAAGDirectorAug 07 '26Proposed Sale45.8327,3321,252,492Aug 07 04:52 PM
Bickerstaff GeorgeDirectorAug 05 '26Sale46.2820,000925,700134,061Aug 06 04:10 PM
COURNOYER CHRISTINEDirectorAug 04 '26Sale46.9416,000750,97342,943Aug 06 04:10 PM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
ARKGARK Genomic Revolution ETFAUM: 1.97B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
IBBiShares Biotechnology ETFAUM: 11.36B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-290.7000.2550.350139.36121.966
2026Q22026-07-300.3700.2322.071131.95114.055
2026Q12026-04-280.3400.1340.053117.7102.036
2025Q42026-02-240.1200.020-0.080108.39103.276
2025Q32025-11-040.030-0.0820.031100.0695.386
2025Q22025-08-06-0.160-0.096-0.15886.6890.576
2025Q12025-04-30-0.190-0.207-0.18784.6984.356
2024Q42025-02-261.510-0.4081.50686.5884.116
2024Q32024-11-04-0.140-0.246-0.14082.8880.046
2024Q22024-07-31-0.030-0.399-0.02792.2767.855
2024Q12024-05-09-0.320-0.474-0.32272.0563.135
2023Q42024-02-28-2.210-0.447-2.21265.5763.666
2023Q32023-11-08-0.430-0.588-0.43467.1953.146
2023Q22023-08-08-0.460-0.545-0.46370.3061.775
2023Q12023-05-10-0.440-0.323-0.44377.2680.705
2022Q42023-02-27-0.340-0.334-0.34282.3881.675

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.520-0.563-0.521127.07127.03
2020FY-0.400-0.476-0.403192.19189.06
2021FY-0.590-0.296-0.587296.4294.49
2022FY-1.440-1.431-1.437321.79321.02
2023FY-3.540-1.830-3.539280.32278.36
2024FY0.930-0.8950.928333.79331.35
2025FY0.580-0.299-0.400379.81374.6
2026FY-1.779--524.83
2027FY-1.564--571.96
2028FY-2.175--658.13
2029FY-2.850--733
2030FY-3.660--844.5

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10870135.84135.4136.3
2026Q4S2026-10-30770135.9135.4136.3
2026Q4S2026-10-29700123.51122.1124.11
2026Q4S2026-10-26700123.51122.1124.11
2026Q4S2026-10-18700123.51122.1124.11
2026Q4S2026-10-16710123.51122.1124.11
2026Q4S2026-10-14710123.51122.1124.11
2026Q4S2026-09-28760123.51122.1124.11
2026Q4S2026-09-23870123.62122.1124.4
2026Q4S2026-09-22870123.62122.1124.4
2026Q4S2026-09-21870123.61122.1124.4
2026Q4S2026-09-01870123.61122.1124.4
2026Q4S2026-08-31870123.61122.1124.4
2026Q4S2026-08-04770123.6122.1124.4

Estimate history

EPS, annual-2.38-1.312-0.521-0.403-0.587-1.437-3.5390.928-0.4012.3943
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.141.506-0.187-0.1580.031-0.080.0532.0710.351
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual48.32476.569127.068192.194296.397321.793280.324333.785379.805497.4
Period201720182019202020212022202320242025TTM
Sales, quarterly82.88386.57984.68586.679100.055108.386117.7131.948139.362
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual28.82541.38542.49849.44152.92353.53351.50354.77150.91752.461
Period201720182019202020212022202320242025MRQ
Shares, quarterly53.10754.77155.46353.2251.40750.91751.27551.48352.461
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue497.40379.81333.79280.32321.79296.40192.19127.0776.57
Cost of Goods Sold Incl. D&A146.70125.84112.15104.46114.4698.9964.6246.7633.99
Gross Profit350.70253.96221.63175.87207.33197.41127.5880.3142.58
Selling, General and Administrative Excl. Other346.41276.09274.90277.77284.56226.83150.10104.2557.14
Research and Development84.4271.4372.4181.8790.3976.5348.9430.7114.51
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income4.28-22.12-53.27-101.90-77.23-29.43-22.53-23.93-14.56
Interest Expense0.000.000.000.000.000.00--3.70
Unusual Expense0.768.66-94.03101.452.821.94-3.320.2829.77
Net Income Before Taxes124.22-21.0852.86-190.14-76.23-32.09-19.75-23.95-48.22
Income Taxes-4.410.270.310.140.38-1.43-1.04-1.98-1.43
Consolidated Net Income128.63-21.3552.55-190.28-76.61-30.66-18.71-21.97-46.78
Net Income From Continuing Operations128.63-21.3552.55-190.28-76.61-30.66-18.71-21.97-46.76
Net Income128.63-21.3552.55-190.28-76.61-30.66-18.71-21.97-46.76
EPS (Recurring)2.35-0.29-0.23-2.22-1.40-0.56-0.45-0.52-0.73
EPS (Basic, Before Extraordinaries)2.49-0.401.00-3.54-1.44-0.59-0.40-0.52-1.31
EPS (Diluted)2.39-0.400.93-3.54-1.44-0.59-0.40-0.52-1.31
EBITDA27.97-1.71-33.51-82.08-61.22-17.54-12.98-18.41-10.35
Non-Operating Income (Expense)120.709.7012.0913.213.81-0.72-0.540.27-0.18
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense30.1527.5452.4638.7836.7826.3417.0816.367.14
Price To Earnings Ratio33.7333.73-------
Price To Sales Ratio7.192.643.632.301.898.0217.527.1611.70
Gross Margin70.5166.8766.4062.7464.4366.6066.3863.2055.61
Operating Margin0.86-5.82-15.96-36.35-24.00-9.93-11.72-18.83-19.02
Net Margin25.86-5.6215.74-67.88-23.81-10.34-9.74-17.29-61.06
Shares Outstanding52.4650.9254.7751.5053.5352.9249.4442.5041.38
Market Capitalization4,243.884,243.881,148.30649.18610.862,401.443,568.68915.341,025.31

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue139.36131.95117.70108.39100.0686.6884.6986.58
Cost of Goods Sold Incl. D&A41.1035.1434.2736.1831.3129.3129.0428.79
Gross Profit98.2696.8183.4372.2068.7557.3755.6457.79
Selling, General and Administrative Excl. Other90.1596.5581.6378.0966.7368.1463.6666.11
Research and Development21.3222.3821.4219.3116.7716.8318.5216.45
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income8.110.261.80-5.882.01-10.77-8.01-8.32
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.600.162.260.355.36-92.70
Net Income Before Taxes10.69114.522.78-3.761.66-8.69-10.2987.87
Income Taxes-8.603.88-0.030.34-0.01-0.120.060.17
Consolidated Net Income19.29110.642.81-4.111.68-8.57-10.3587.70
Net Income From Continuing Operations19.29110.642.81-4.111.68-8.57-10.3587.70
Net Income19.29110.642.81-4.111.68-8.57-10.3587.70
EPS (Recurring)0.352.070.06-0.080.06-0.15-0.120.39
EPS (Basic, Before Extraordinaries)0.372.150.05-0.080.03-0.16-0.191.62
EPS (Diluted)0.352.070.05-0.080.03-0.16-0.191.51
EBITDA17.184.307.12-0.627.17-6.12-3.07-4.26
Non-Operating Income (Expense)2.58114.261.582.281.912.443.083.49
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.638.397.746.396.657.447.0613.04
Price To Earnings Ratio33.73--15.8014.2416.9617.45-
Price To Sales Ratio7.193.322.232.542.183.112.833.73
Gross Margin70.5173.3770.8866.6268.7166.1965.7066.75
Operating Margin5.820.191.53-5.432.01-12.43-9.46-9.61
Net Margin13.8483.852.39-3.791.67-9.88-12.23101.29
Shares Outstanding52.4651.4851.2750.9251.4153.2255.4654.77
Market Capitalization4,243.881,472.30889.12968.99773.921,088.00983.811,148.30

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments177.21260.65235.42293.09348.49224.7038.2264.6216.89
Short Term Receivables42.6364.6151.0666.3159.7634.6224.069.762.99
Inventories26.7019.5019.4719.2317.1910.016.014.945.53
Other Current Assets10.597.077.769.227.933.763.631.791.35
Total Current Assets257.13351.83313.71387.85433.36273.1071.9281.1126.77
Net Property, Plant & Equipment55.7357.8965.1470.2240.0425.939.164.132.08
Total Investments and Advances24.720.580.590.520.210.270.260.199.58
Intangible Assets72.3078.5286.0480.5787.1868.2169.4045.2645.14
Deferred Tax Assets11.5914.4117.7917.8811.5110.586.533.492.64
Other Assets3.352.221.353.835.831.001.000.000.00
Total Assets424.82505.46484.62560.87578.13379.09158.26134.1986.20
Short Term Debt Incl. Current Port. of LT Debt6.516.105.945.593.962.033.230.1715.73
Accounts Payable9.997.6912.879.9413.349.655.514.713.39
Other Current Liabilities73.3575.5859.2660.4460.0157.5326.1014.6223.78
Total Current Liabilities89.8589.3778.0775.9777.3069.2234.8319.5042.91
Long Term Debt19.6822.2628.2833.4117.3916.140.070.2518.34
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities11.7814.5817.9317.8811.9211.888.506.467.57
Other Liabilities0.420.8299.012.705.634.1815.8612.0523.34
Total Liabilities121.72127.03223.29129.96112.25101.4159.2638.2692.16
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity303.10378.43261.33430.91465.88277.6899.0095.93-6.13
Total Shareholders Equity303.10378.43261.33430.91465.88277.6899.0095.93-6.13
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.18
Total Equity303.10378.43261.33430.91465.88277.6899.0095.93-5.95
Total Liabilities & Stockholders Equity424.82505.46484.62560.87578.13379.09158.26134.1986.20
Book Value Per Share5.956.915.078.058.805.622.332.32-0.21
Tangible Book Value Per Share4.535.483.406.547.164.240.701.22-1.78
Full-Time Employees765650643738645475386231179
Price to Book Ratio9.064.161.651.405.1712.909.2610.85-532.66
Return on Assets-4.5910.62-36.40-13.45-6.41-6.97-15.02-42.43-66.88
Return on Equity-6.2716.43-54.98-17.09-8.25-9.94-22.54-104.14-831.12
Return on Invested Capital-6.6213.11-65.70-16.50-6.34-6.37-22.17-48.61-454.51
Quick Ratio2.563.723.774.855.383.801.893.910.49
Current Ratio2.863.944.025.105.613.952.074.160.62

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income128.63-21.3552.55-190.28-76.61-30.66-18.71-21.97-46.78
Depreciation23.6920.4219.7619.8216.0111.889.547.144.21
Other Funds (Non Cash)-82.5539.1568.0545.4849.5840.4525.2022.4739.43
Funds from Operations69.7938.23140.17-124.42-11.2420.3015.016.36-4.74
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.773.81-102.12106.03-14.00-39.5918.42-9.130.74
Cash from Operating Activities69.0242.0338.05-18.39-25.24-19.2933.43-2.77-4.01
Capital Expenditures-9.26-6.59-6.48-9.24-24.33-20.26-10.36-3.35-7.24
Net Assets From Acquisitions-145.770.000.00-6.68-0.61-15.430.00-18.23-0.69
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments99.098.756.6354.87-203.5683.41-90.03-1.000.00
Purchase of Investments-103.92-145.93-160.29-201.16-315.14-5.50-90.03-1.000.00
Sale Or Maturity of Investments203.01154.67166.92256.04111.5988.910.000.000.00
Other Uses0.000.00-0.63-0.960.000.000.000.000.00
Other Sources164.790.000.002.460.000.000.000.00-
Cash from Investing Activities108.852.16-0.4840.45-228.5047.71-100.39-22.58-7.93
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-1.70-79.779.81-25.924.02203.77167.864.4265.67
Repurchase of Common Pref Stock-24.44-87.77-0.52-27.54-0.640.000.000.000.00
Sale of Common Pref Stock22.738.0010.331.624.67203.77167.864.4265.67
Proceedsfrom Stock Options2.502.271.401.502.23190.99159.500.7653.20
Issuance or Reduction of Debt, Net0.000.000.000.000.00-0.07-0.18-0.17-14.48
Change in Long Term Debt0.000.000.000.000.00-0.07-0.18-0.17-13.81
Issuance of Long Term Debt0.000.000.000.000.000.000.000.0014.28
Reduction of Long Term Debt0.000.000.000.000.00-0.07-0.18-0.17-28.09
Net Financing Active Other Cash Flow-16.27-13.62-15.42-3.68-8.56-18.07-4.53-4.38-0.92
Other Financing Activities Uses-16.27-13.62-15.42-3.68-8.56-18.07-4.53-4.38-0.92
Cash from Financing Activities-17.97-93.39-5.61-29.61-4.54185.64163.15-0.1350.27
Exchange Rate Effect0.01-0.090.53-0.110.02-0.300.27-0.850.00
Net Change in Cash159.90-49.2932.49-7.66-258.25213.7696.46-26.3338.33
Free Cash Flow59.7636.1231.56-26.73-46.47-32.8526.32-4.97-6.04
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow59.8127.8038.41---127.94--
Deferred Taxes & Investment Tax Credit-0.02-0.190.57-0.21-1.38-1.02-1.28-1.61

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments250.48373.64187.18177.21194.22186.25
Short Term Receivables47.7334.3844.5942.6347.8467.36
Inventories9.146.9826.4026.7028.3327.91
Other Current Assets13.9414.2311.2310.5929.8925.76
Total Current Assets321.30429.22269.39257.13300.28307.30
Net Property, Plant & Equipment50.5543.0454.3655.7354.8957.31
Total Investments and Advances1.410.5211.4524.720.550.55
Intangible Assets261.4954.5272.4472.3073.7876.37
Deferred Tax Assets---11.59--
Other Assets6.715.683.423.352.802.73
Total Assets641.46532.99411.06424.82432.31444.26
Short Term Debt Incl. Current Port. of LT Debt8.696.056.666.516.436.34
Accounts Payable10.819.499.079.9911.609.86
Other Current Liabilities119.4878.1663.4373.3581.0276.97
Total Current Liabilities138.9793.7079.1589.8599.0493.18
Long Term Debt20.3213.2017.8419.6821.2122.78
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.540.090.1311.780.120.13
Other Liabilities14.170.410.410.420.790.80
Total Liabilities174.00107.3997.53121.72121.17116.89
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity467.46425.60313.54303.10311.14327.37
Total Shareholders Equity467.46425.60313.54303.10311.14327.37
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity467.46425.60313.54303.10311.14327.37
Total Liabilities & Stockholders Equity641.46532.99411.06424.82432.31444.26
Book Value Per Share8.918.276.115.956.056.15
Tangible Book Value Per Share3.937.214.704.534.624.72
Full-Time Employees---765--
Price to Book Ratio9.064.662.923.112.362.86
Return on Assets23.9622.72-1.82-4.5915.5013.47
Return on Equity33.0429.49-2.36-6.2724.1120.73
Return on Invested Capital3.9625.210.85-1.270.50-2.45
Quick Ratio2.254.513.072.562.753.00
Current Ratio2.314.583.402.863.033.30

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income19.29110.642.81-4.111.68-8.57
Depreciation9.064.055.325.265.165.05
Other Funds (Non Cash)0.24-101.6710.858.0311.669.65
Funds from Operations28.6013.0218.989.2018.506.13
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-15.8817.59-14.6412.1718.863.76
Income Taxes Payable----0.000.00
Cash from Operating Activities12.7230.604.3321.3637.369.89
Capital Expenditures-1.61-1.86-3.82-1.97-1.98-1.01
Net Assets From Acquisitions-145.770.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.50117.6514.88-32.9414.3324.40
Purchase of Investments-0.50-2.00-39.85-61.57-17.07-14.81
Sale Or Maturity of Investments0.00119.6554.7328.6331.4039.21
Other Uses0.000.000.000.000.000.00
Other Sources0.00164.790.000.000.000.00
Cash from Investing Activities-147.88280.5911.06-34.9112.3523.40
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock17.47-9.481.10-10.79-25.33-47.57
Repurchase of Common Pref Stock0.00-12.230.00-12.21-25.56-50.00
Sale of Common Pref Stock17.472.751.101.410.232.43
Proceedsfrom Stock Options0.001.510.990.000.001.40
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-4.57-6.02-4.01-1.67-1.15-6.24
Other Financing Activities Uses-4.57-6.02-4.01-1.67-1.15-6.24
Cash from Financing Activities12.90-15.50-2.91-12.46-26.48-53.81
Exchange Rate Effect0.00-0.010.010.01-0.01-0.01
Net Change in Cash-122.27295.6812.49-26.0123.22-20.53
Free Cash Flow11.1028.750.5119.3936.058.89
Price to Free Cash Flow59.8117.9714.2226.6721.0689.33

Revenue breakdown

Patient And Digital Solutions2024: 43.62M 2025: 56.93M
Product2024: 40.78M 2025: 48.38M
Service2024: 249.38M 2025: 274.50M
Non-US2024: 16.05M 2025: 19.87M
United States2024: 317.73M 2025: 359.94M
Non-US2024: 16.05M 2025: 19.87M
United States2024: 317.73M 2025: 359.94M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.03%7.2M47.8M1.33M
2026-10-1514.26%6.7M47.1M1.32M
2026-09-3013.99%6.6M47.1M1.21M
2026-09-1513.38%6.3M47.1M1.15M
2026-08-3112.39%5.8M47.1M1.11M
2026-08-1412.31%5.8M47.1M1.03M
2026-07-3113.12%6.1M46.8M934.02K
2026-07-1513.25%6.2M46.7M847.47K
2026-06-3017.85%8.3M46.7M809.87K
2026-06-1518.06%8.4M46.7M724.13K
2026-05-2913.66%6.4M46.6M688.65K
2026-05-1514.11%6.5M46.1M683.42K
2026-04-3014.95%6.9M46.1M708.92K
2026-04-1513.99%6.4M45.7M630.62K
2026-03-3114.06%6.4M45.6M696.99K
2026-03-1314.28%6.5M45.6M689.00K
2026-02-2713.75%6.3M45.6M737.17K
2026-02-1313.27%6.1M45.8M750.14K
2026-01-3012.55%5.8M45.8M882.89K
2026-01-1512.06%5.6M46.3M943.98K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5077.0081.000.000.0000.000.000.999-0.0220.000
call5.0074.5078.500.0018.7730.000.000.997-0.0550.001
call7.5072.0076.000.0014.5810.000.000.996-0.0570.001
call10.0069.5073.500.0012.3090.000.000.996-0.0590.002
call12.5067.0071.000.0010.7720.000.000.995-0.0590.002
call15.0064.5068.5021.989.6194.000.000.994-0.0600.002
call17.5062.0066.004.358.7010.000.000.994-0.0600.002
call20.0059.5063.5027.607.9417.000.000.993-0.0600.002
call22.5057.0061.0027.397.29292.000.000.992-0.0610.003
call25.0054.5058.5039.036.72792.000.000.992-0.0610.003
call30.0049.5053.5034.955.77824.000.000.990-0.0600.003
call35.0044.5048.5032.604.99731.000.000.988-0.0600.004
call40.0039.7043.5026.204.17262.000.000.987-0.0600.004
call45.0034.8038.5042.503.55812.000.000.984-0.0590.005
call50.0029.6033.5033.953.05789.000.000.915-0.3050.020
call55.0024.9028.5030.002.6393970.000.900-0.2910.022
call60.0019.6024.0025.002.3138.000.000.881-0.2750.025
call65.0014.5019.0015.001.8983150.000.855-0.2540.029
call70.0010.4013.5014.001.3622,2900.000.818-0.2270.033
call75.006.508.408.381.0972,06210.000.749-0.2000.040
call80.002.806.003.501.0725131.000.571-0.2780.050
call85.000.252.652.000.82856.0020.000.389-0.2320.048
call90.000.001.801.370.94425612.000.267-0.2240.041
call95.000.002.151.011.1901240.000.226-0.2580.038
call1000.051.350.201.27310.000.000.171-0.2330.032
put2.500.000.050.058.9570.000.00-0.001-0.0200.000
put5.000.004.900.008.1330.000.00-0.003-0.0490.001
put7.500.004.900.006.8510.000.00-0.004-0.0510.001
put10.000.004.900.285.9840.000.00-0.004-0.0520.002
put12.500.004.900.265.3311.000.00-0.005-0.0520.002
put15.000.004.900.054.8090.000.00-0.006-0.0520.002
put17.500.005.000.304.6181.000.00-0.006-0.0580.002
put20.000.004.400.684.22610.000.00-0.007-0.0580.002
put22.500.004.903.253.85210.000.00-0.008-0.0580.003
put25.000.004.900.053.5859.000.00-0.008-0.0580.003
put30.000.004.900.053.0563.000.00-0.010-0.0570.003
put35.000.004.900.162.6161.000.00-0.012-0.0560.004
put40.000.004.902.532.2351.001.00-0.013-0.0550.004
put45.000.000.150.101.8996,9230.00-0.016-0.0540.005
put50.000.004.902.382.69127.001.00-0.085-0.3000.020
put55.000.004.900.182.27637.000.00-0.100-0.2850.022
put60.000.004.900.201.8914610.00-0.119-0.2680.025
put65.000.004.700.201.52660.000.00-0.145-0.2470.029
put70.000.001.951.221.17361.000.00-0.182-0.2200.033
put75.000.201.601.150.81910.002.00-0.251-0.1910.040
put80.000.703.902.600.90011.004.00-0.429-0.2690.050
put85.004.206.505.100.84939.002.00-0.611-0.2220.048
put90.008.5011.209.001.097654646-0.733-0.2140.041
put95.0011.6015.4011.351.1545.000.00-0.774-0.2470.038
put10016.5020.5012.401.3974.000.00-0.829-0.2220.032

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10SCHEDULE 13GSEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-09-168-K/A2026-06-30SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-12SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-12SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-07144Filing for proposed sale of securities under Rule 144.SEC
2026-08-07SCHEDULE 13G/ASEC
2026-08-07SCHEDULE 13GSEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-04SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11004.82M1
2026-100000
2026-090000
2026-08003.90M4
2026-07005.50M2
2026-06002.52M6
2026-0500270.26K3
2026-0400217.16K1
2026-030000
2026-020091.29K1
2026-0100626.03K3
2025-1200139.80K1
2025-110041.72K1

Institutional holders

Manager% owned
BlackRock, Inc.9.32%
STATE STREET CORP4.78%
VANGUARD CAPITAL MANAGEMENT LLC4.25%
DEERFIELD MANAGEMENT COMPANY, L.P.3.87%
ARK Investment Management LLC3.78%
BAMCO INC /NY/3.75%
GEODE CAPITAL MANAGEMENT, LLC2.86%
Chevy Chase Trust Holdings, LLC2.78%
Ophir Asset Management Pty Ltd2.45%
RENAISSANCE TECHNOLOGIES LLC2.41%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
ARK Genomic Revolution ETF2.96%
BARON DISCOVERY FUND2.66%
iShares Russell 2000 ETF2.60%
State Street(R) SPDR(R) S&P(R) Biotech ETF2.21%
VANGUARD EXTENDED MARKET INDEX FUND1.14%
Fidelity Small Cap Index Fund1.09%
First Eagle Small Cap Opportunity Fund0.94%
iShares Russell 2000 Growth ETF0.92%
Strategic Advisers U.S. Total Stock Fund0.90%

OakChart. CDNA. Cached 15 minutes.